A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
Clinical trial NCT03235778 · COMPLETED
Trial details
- NCT number
- NCT03235778
- Sponsor
- Yiling Pharmaceutical Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2018-03-19
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.